Directory

>

Hasane Ratni

avatar

Hasane Ratni

Vice-President, Chemistry, Skyhawk Therapeutics | Skyhawk Therapeutics

Basel, Basel-City, Switzerland

View contact details (it's free)

Hasane Ratni

Summary

Hasane Ratni is a seasoned drug hunter with a remarkable track record of designing six molecules that have successfully advanced to human clinical trials. As the Vice-President of Chemistry at Skyhawk Therapeutics, he played a pivotal role in the invention of Risdiplam, the first approved small molecule targeting RNA. With over 80 patent applications and 35 peer-reviewed publications in prestigious journals like Science and Nature, Hasane is a prolific contributor to the field. His accolades include the Senior Industrial Award from the Swiss Chemical Society and the Drug Discovery of the Year Award for two consecutive years. Hasane's extensive experience in pharmaceutical research is complemented by his leadership roles at F. Hoffmann La Roche, where he has led various projects in neuroscience and rare diseases. His educational background includes a Ph.D. in Organic Chemistry from the University of Geneva and post-doctoral studies at the University of Tokyo. Hasane is not only a scientist but also a thought leader in drug discovery, with a passion for innovation and collaboration in the pharmaceutical industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Hasane Ratni

Work Experience

company logo

Vice-President, Chemistry, Skyhawk Therapeutics at

Skyhawk Therapeutics

May 2022 - Present

company logo

Distinguished Scientist and Project team leader at

F Hoffmann La Roche

October 2020 - May 2022

company logo

Expert Scientist, Project Leader Discovery Chemistry (Neuroscience and rare disease) at

F Hoffmann La Roche

May 2002 - October 2020

company logo

Expert Scientist and project team leader at

F Hoffmann La Roche

November 2018 - October 2020

company logo

Section head, Medicinal Chemistry (Neuroscience, Ophtalmology and Rare Disease) at

F Hoffmann La Roche

January 2018 - November 2018

💼

Medicinal Chemist at

Chugai Pharmaceuticals

January 2005 - June 2005

Logos provided by Logo.dev

Hasane Ratni

Education

université de Tokyo, Post-Doctoral Studies

January 2001 - January 2002

University of Geneva, Doctor Of Philosophy (Ph.D.)

January 1997 - January 2001

École Polytechnique, D.E.A (Master Degree) Multinational De Chimie Moleculaire

January 1998

Frequently Asked Questions about Hasane Ratni

What is Hasane Ratni email address?

Hasane Ratni's primary email address is ******@skyhawktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Hasane Ratni work for?

Hasane Ratni is a Vice-President, Chemistry, Skyhawk Therapeutics at Skyhawk Therapeutics, a company specializing in Commercial physical research.

Where Hasane Ratni graduated from?

Hasane Ratni holds a degree in from université de Tokyo.

How can I directly contact Hasane Ratni?

To contact Hasane Ratni directly, you can use the email address ******@skyhawktx.com. Complete contact information is available upon registration with Muraena.

Is Hasane Ratni an immigrant?

Yes, Hasane Ratni is an immigrant and currently based in Switzerland

Who is Hasane Ratni?

Hasane Ratni is a seasoned drug hunter with a remarkable track record of designing six molecules that have successfully advanced to human clinical trials. As the Vice-President of Chemistry at Skyhawk Therapeutics, he played a pivotal role in the invention of Risdiplam, the first approved small molecule targeting RNA. With over 80 patent applications and 35 peer-reviewed publications in prestigious journals like Science and Nature, Hasane is a prolific contributor to the field. His accolades include the Senior Industrial Award from the Swiss Chemical Society and the Drug Discovery of the Year Award for two consecutive years. Hasane's extensive experience in pharmaceutical research is complemented by his leadership roles at F. Hoffmann La Roche, where he has led various projects in neuroscience and rare diseases. His educational background includes a Ph.D. in Organic Chemistry from the University of Geneva and post-doctoral studies at the University of Tokyo. Hasane is not only a scientist but also a thought leader in drug discovery, with a passion for innovation and collaboration in the pharmaceutical industry.

Hasane`s contact details

mail

******@skyhawktx.com

Colleagues

avatar
Sergey Paushkin

Chief Scientific Officer

avatar
Kyle Dow

Vice President Corporate Development

avatar
Meghan Miller

Executive Director, Translational Biomarkers

avatar
Botao Liu

Executive Director, Bioinformatics

avatar
Douglas Faller

Chief Medical Officer

avatar
Joseph Duffy

Senior Vice President Chemistry

avatar
John Mckeague

Senior Vice President Legal

avatar
Amparo Garcia Lopez

Executive Director Discovery Biology

View Contact details (it's free)
Request Profile Removal